Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03509012
Title Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid Tumors (CLOVER)
Acronym CLOVER
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Research Site Tucson Arizona 85719 United States Details
Research Site Aurora Colorado 80045 United States Details
Research Site Houston Texas 77090 United States Details
Research Site Koto-ku 135-8550 Japan Details
Research Site Sunto-gun 411-8777 Japan Details
Research Site Seoul 03080 Korea, Republic of Details
Research Site Seoul 03722 Korea, Republic of Details
Research Site Seoul 05505 Korea, Republic of Details
Research Site Seoul 06351 Korea, Republic of Details
Research Site Badalona 08916 Spain Details
Research Site Madrid 28007 Spain Details
Research Site Málaga 29010 Spain Details
Research Site Taichung 40705 Taiwan Details
Research Site Taipei 10002 Taiwan Details
Research Site Taipei 112 Taiwan Details
Research Site Taoyuan City 333 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field